CRTX
Cortexyme Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Cortexyme, Inc. is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Based upon the evidence generated to date, Cortexyme is currently advancing its lead therapeutic candidate, atuzaginstat (COR388), in the GAIN Trial, an ongoing Phase 2/3 clinical trial in patients with mild to moderate Alzheimer's disease. Cortexyme is targeting a specific, infectious pathogen found in the brain and other organs and tied to degeneration and inflammation in humans and animal models.
Market Cap: 58.8 Million
Primary Exchange: NASDAQ
Website: www.cortexyme.com
Shares Outstanding: 30.2 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.4322459168116795
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Ethical Flags
Longest drawdown: 450 trading days
From: 2020-02-14 To: 2021-08-06
Lowest Point:
Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019
via: Business Wire at 2019-06-10 04:00:00:000
-- Event will be webcast, with Cortexyme presentation expected to start at 2:05 p.m. EDT tomorrow afternoon Cortexyme, Inc. (Nasdaq: CRTX) today announced that Casey Lynch, the companys chief executive officer, chairman, and co-founder, will present at a National Academies o… read more...
Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019
via: Business Wire at 2019-06-10 04:00:00:000
-- Event will be webcast, with Cortexyme presentation expected to start at 2:05 p.m. EDT tomorrow afternoon Cortexyme, Inc. (Nasdaq: CRTX) today announced that Casey Lynch, the companys chief executive officer, chairman, and co-founder, will present at a National Academies o… read more...
Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019
via: Business Wire at 2019-06-10 04:00:00:000
-- Event will be webcast, with Cortexyme presentation expected to start at 2:05 p.m. EDT tomorrow afternoon Cortexyme, Inc. (Nasdaq: CRTX) today announced that Casey Lynch, the companys chief executive officer, chairman, and co-founder, will present at a National Academies o… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|